Page last updated: 2024-08-23

epirubicin and Leukemia, Myeloid, Acute

epirubicin has been researched along with Leukemia, Myeloid, Acute in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19902 (14.29)18.7374
1990's9 (64.29)18.2507
2000's2 (14.29)29.6817
2010's1 (7.14)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amarillo, I; Fisher, SI; Rashidi, A1
Bergh, J; Bliss, J; Bonneterre, J; Cesana, B; Coombes, RC; Fargeot, P; Folin, A; Fumoleau, P; Giuliani, R; Hery, M; Kerbrat, P; Nilsson, J; Onida, F; Piccart, M; Praga, C; Rogers, D; Shepherd, L; Therasse, P; Wils, J1
Ferretti, G; Papaldo, P1
Bettelheim, P; Kasparu, H; Kolb, A; Krieger, O; Lutz, D1
Fujihara, M; Kyo, T; Myoken, Y; Sugata, T1
Levine, M; Myles, J; Ottaway, J; Shepherd, L1
Deguchi, S; Fujita, M; Honda, K; Kikuchi, T; Miyata, A1
Ciarli, M; Laurenti, L; Leone, G; Menichella, G; Piccirillo, N; Salutari, P; Sica, S1
Hurkacz, M; Kotlarek-Haus, S; Orzechowska-Juzwenko, K; Usnarska-Zubkiewicz, L; Wiela-Hojenska, A1
Paul, C; Sundman-Engberg, B; Tidefelt, U2
Jiang, CJ; Liang, DC1
Capalbo, S; Dione, R; Liso, V; Pavone, V; Specchia, G1
Aoki, N; Imai, Y; Murohashi, I; Nara, N; Tanikawa, S; Yamashita, Y1

Trials

1 trial(s) available for epirubicin and Leukemia, Myeloid, Acute

ArticleYear
Phenazone as a marker of liver-metabolic function in patients with acute leukemia.
    International journal of clinical pharmacology and therapeutics, 1999, Volume: 37, Issue:5

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibiotics, Antineoplastic; Antineoplastic Agents; Antipyrine; Biomarkers; Biotransformation; Epirubicin; Female; Half-Life; Humans; Leukemia, Myeloid, Acute; Liver; Male; Microsomes, Liver

1999

Other Studies

13 other study(ies) available for epirubicin and Leukemia, Myeloid, Acute

ArticleYear
BRCA2-associated therapy-related acute myeloid leukemia.
    Medical oncology (Northwood, London, England), 2015, Volume: 32, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma in Situ; Carcinoma, Ductal, Breast; Cyclophosphamide; Docetaxel; Epirubicin; Female; Fluorouracil; Genes, BRCA2; Humans; Leukemia, Myeloid, Acute; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Taxoids

2015
Risk of acute myeloid leukemia and myelodysplastic syndrome in trials of adjuvant epirubicin for early breast cancer: correlation with doses of epirubicin and cyclophosphamide.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Jun-20, Volume: 23, Issue:18

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Data Interpretation, Statistical; Epirubicin; Female; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute; Middle Aged; Myelodysplastic Syndromes; Randomized Controlled Trials as Topic; Risk Factors

2005
Acute myeloid leukaemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
    Breast cancer research and treatment, 2008, Volume: 109, Issue:1

    Topics: Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Epirubicin; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Proportional Hazards Models; Treatment Outcome

2008
[Autologous stem cell harvesting after high dosage chemo- and/or growth factor therapy].
    Wiener medizinische Wochenschrift (1946), 1995, Volume: 145, Issue:2-3

    Topics: Adult; Blood Cell Count; Combined Modality Therapy; Cyclophosphamide; Cytapheresis; Epirubicin; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Lymphoma; Male; Middle Aged; Neoplasms; Remission Induction; Survival Rate; Transplantation, Autologous

1995
Oral Fusarium infection in a granulocytopenic patient with acute myelogenous leukemia: a case report.
    Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 1995, Volume: 24, Issue:5

    Topics: Acute Kidney Injury; Aged; Agranulocytosis; Amphotericin B; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Epirubicin; Etoposide; Fatal Outcome; Fusarium; Gingival Diseases; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Male; Maxillary Diseases; Mercaptopurine; Mycoses; Necrosis; Prednisolone; Ulcer; Vindesine

1995
Therapy-related leukemia associated with high-dose 4-epi-doxorubicin and cyclophosphamide used as adjuvant chemotherapy for breast cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1994, Volume: 12, Issue:11

    Topics: Adult; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Epirubicin; Female; Humans; Leukemia, Myeloid, Acute; Middle Aged

1994
[Therapy-related AML(M2) with t(8;21) that developed three years after chemotherapy for hepatocellular carcinoma].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1996, Volume: 37, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Hepatocellular; Chromosomes, Human, Pair 21; Chromosomes, Human, Pair 8; Doxorubicin; Epirubicin; Etoposide; Humans; Leukemia, Myeloid, Acute; Liver Neoplasms; Male; Middle Aged; Neoplasms, Second Primary; Translocation, Genetic

1996
Secondary leukemia after autologous peripheral blood progenitor cell transplantation for breast cancer.
    Leukemia, 1997, Volume: 11, Issue:11

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Neoplasms, Second Primary

1997
Intracellular uptake and cytotoxic effect in vitro of doxorubicin and epirubicin in human leukemic and normal hematopoietic cells.
    Cancer chemotherapy and pharmacology, 1991, Volume: 29, Issue:1

    Topics: Bone Marrow Cells; Cell Separation; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Doxorubicin; Epirubicin; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid, Acute; Tumor Cells, Cultured

1991
Epirubicin and cytosine arabinoside for the induction therapy of childhood acute nonlymphocytic leukemia.
    American journal of hematology, 1991, Volume: 38, Issue:4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Epirubicin; Humans; Leukemia, Myeloid, Acute; Remission Induction

1991
Continuous infusion chemotherapy with epirubicin and vincristine in relapsed and refractory acute leukemia.
    Acta haematologica, 1990, Volume: 83, Issue:3

    Topics: Acute Disease; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Epirubicin; Female; Humans; Infusions, Intravenous; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Vincristine

1990
Comparison of the intracellular pharmacokinetics of doxorubicin and 4'-epi-doxorubicin in patients with acute leukemia.
    Cancer chemotherapy and pharmacology, 1989, Volume: 24, Issue:4

    Topics: Acute Disease; Chromatography, High Pressure Liquid; Doxorubicin; Drug Interactions; Epirubicin; Humans; Leukemia; Leukemia, Myeloid, Acute; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tumor Cells, Cultured

1989
Effects on leukemic clonogenic cells in murine myeloid leukemia of 1-beta-D-arabinofuranosylcytosine and the anthracyclines adriamycin, daunomycin, aclacinomycin A, and 4'-epidoxorubicin.
    Cancer research, 1987, May-01, Volume: 47, Issue:9

    Topics: Aclarubicin; Animals; Antibiotics, Antineoplastic; Clone Cells; Colony-Forming Units Assay; Cytarabine; Daunorubicin; Doxorubicin; Epirubicin; Kinetics; Leukemia, Myeloid, Acute; Mice; Naphthacenes

1987